BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu F, Lin X, Shan SK, Li F, Xu F, Zhong JY, Guo B, Zheng MH, Wang Y, Mo ZH, Yuan LQ. The Suppression of miR-199a-3p by Promoter Methylation Contributes to Papillary Thyroid Carcinoma Aggressiveness by Targeting RAP2a and DNMT3a. Front Cell Dev Biol 2020;8:594528. [PMID: 33365310 DOI: 10.3389/fcell.2020.594528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Masalha M, Meningher T, Mizrahi A, Barzilai A, Tabibian-Keissar H, Gur-Wahnon D, Ben-Dov IZ, Kapenhas J, Jacob-Hirsch J, Leibowitz R, Sidi Y, Avni D. MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. Int J Mol Sci 2022;23. [PMID: 36499729 DOI: 10.3390/ijms232315401] [Reference Citation Analysis]
2 Chen D, Jiang X, Luo H, Hua Q, Zhang F. CircPTPRM accelerates malignancy of papillary thyroid cancer via miR-885-5p/DNMT3A axis. J Clin Lab Anal 2022;:e24688. [PMID: 36098040 DOI: 10.1002/jcla.24688] [Reference Citation Analysis]
3 Meng W, Li Y, Chai B, Liu X, Ma Z. miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer. IJMS 2022;23:8518. [DOI: 10.3390/ijms23158518] [Reference Citation Analysis]
4 Xu F, Zhong J, Guo B, Lin X, Wu F, Li F, Shan S, Zheng M, Wang Y, Xu Q, Lei L, Tan C, Liao X, Yuan L. H19 Promotes Osteoblastic Transition by Acting as ceRNA of miR-140-5p in Vascular Smooth Muscle Cells. Front Cell Dev Biol 2022;10:774363. [DOI: 10.3389/fcell.2022.774363] [Reference Citation Analysis]
5 Zhou Y, Yang Z, Zhang H, Li H, Zhang M, Wang H, Zhang M, Qiu P, Zhang R, Liu J. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022. [DOI: 10.1016/j.bbadis.2022.166353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Craps J, Joris V, Baldeschi L, Daumerie C, Camboni A, Buemi A, Lengelé B, Behets C, Boschi A, Mourad M, Many M, Dessy C. miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves′ Patients. IJMS 2021;23:153. [DOI: 10.3390/ijms23010153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang J, Lei M, Xu Z. Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression. PeerJ 2021;9:e11813. [PMID: 34414029 DOI: 10.7717/peerj.11813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang Y, Shan SK, Guo B, Li F, Zheng MH, Lei LM, Xu QS, Ullah MHE, Xu F, Lin X, Yuan LQ. The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy. Front Endocrinol (Lausanne) 2021;12:671566. [PMID: 34163437 DOI: 10.3389/fendo.2021.671566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]